Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemodynamic Response to Prolonged Dobutamine Infusion
NCT01042873Phase 4Unknown
- Sponsor
- Hadassah Medical Organization
- Start
- Jan 2010
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dobutamine in heart failure (HF), sponsored by Hadassah Medical Organization. Status: unknown.
02
Drugs
dobutamine
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT01042873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01042873.